AGP Picks
View all

Diamond Pharmacy Services' Matthew Risko Earns 340B Apexus Certified Expert (340B ACE) Designation

Matthew Risko Headshot

Matthew Risko leads 340B Project Development for Diamond Pharmacy Services

Diamond Pharmacy Services Logo

INDIANA, PA, UNITED STATES, August 11, 2026 /EINPresswire.com/ -- Diamond Pharmacy Services is proud to announce that Correctional Director of Executive Consultant Pharmacists and Clinical-340B Project Development, Matthew Risko, BS, RPh, AAHIVP, has earned the 340B Apexus Certified Expert (340B ACE) designation through the Apexus Advanced 340B Operations Certificate Program.

The 340B ACE credential recognizes advanced knowledge of 340B program operations, compliance requirements, and industry best practices. The designation is awarded to professionals who demonstrate a comprehensive understanding of the complexities involved in managing and optimizing 340B programs within healthcare organizations.

Through the 340B Program, a correctional system can partner with a covered entity to access discounted outpatient medications, both to improve patient care and to maintain, improve, and expand services for medically vulnerable patients.

As leader of Diamond's Executive Consultant Pharmacists, the OPTICS (Office of Pharmacy Therapeutics and Integrated Clinical Services) Board Certified PharmD Clinical teams, and the company's growing 340B partner initiatives, Risko plays a key role in supporting correctional executive leadership, medical teams, and 340B correctional covered entity partners. This includes navigating increasingly complex pharmacy formulary management, cost containment opportunities, and regulatory requirements. His achievement further strengthens Diamond's ability to provide 340B strategic guidance to correctional facilities and healthcare partners nationwide.

"Matt is always looking for ways to expand his knowledge and bring more value to our clients," said Mark Zilner, R.Ph., CEO of Diamond Pharmacy Services. "The 340B landscape continues to evolve, and earning the 340B ACE designation demonstrates the dedication he brings to helping correctional healthcare organizations and covered entities navigate these challenges with confidence."

The designation reinforces Diamond's commitment to partners by providing specialized pharmacy services and consulting support for correctional healthcare organizations seeking to stretch their limited healthcare resources, improve access to care, maintain compliance, and maximize the impact of their pharmacy programs.

"For me, this certification was an opportunity to deepen my understanding of 340B operations and stay current with the changes affecting healthcare organizations nationwide," said Risko. "I'm excited to apply what I've learned to help our partners strengthen their programs, meet compliance expectations, prepare for new potential regulatory hurdles, and ultimately support better patient care.”

Risko's accomplishment reflects Diamond Pharmacy Services' ongoing investment in advanced clinical and operational expertise to support correctional healthcare providers and partners in an increasingly complex regulatory environment.

About Diamond Pharmacy Services
Diamond Pharmacy Services is the nation's largest correctional pharmacy, providing comprehensive pharmacy services, clinical support, consulting, and technology solutions to correctional healthcare organizations nationwide. Through its team of experienced pharmacists, clinicians, and healthcare professionals, Diamond helps correctional facilities strengthen medication management, navigate complex regulatory requirements, optimize pharmacy operations, and improve patient care outcomes. To learn more about Diamond Pharmacy Services, visit www.diamondpharmacy.com.

Ashley Fritz, Director of Marketing
Diamond Pharmacy Services
afritz@diamondpharmacy.com
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science & Technology Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.